|
Originally published In Press as doi:10.1074/jbc.M011671200 on June 29, 2001
J. Biol. Chem., Vol. 276, Issue 37, 34792-34800, September 14, 2001
ATP Utilization by Yeast Replication Factor C
IV. RFC ATP-BINDING MUTANTS SHOW DEFECTS IN DNA REPLICATION, DNA
REPAIR, AND CHECKPOINT REGULATION*,
Sonja L. Gary
Schmidt,
Angela L.
Pautz, and
Peter M. J.
Burgers
From the Department of Biochemistry and Molecular Biophysics,
Washington University School of Medicine,
St. Louis, Missouri 63110
Received for publication, December 26, 2000, and in revised form, June 27, 2001
 |
ABSTRACT |
Replication factor C is required to load
proliferating cell nuclear antigen onto primer-template junctions,
using the energy of ATP hydrolysis. Four of the five RFC
genes have consensus ATP-binding motifs. To determine the relative
importance of these sites for proper DNA metabolism in the cell, the
conserved lysine in the Walker A motif of RFC1,
RFC2, RFC3, or RFC4 was mutated to
either arginine or glutamic acid. Arginine mutations in all
RFC genes tested permitted cell growth, although poor
growth was observed for rfc2-K71R. A glutamic acid
substitution resulted in lethality in RFC2 and
RFC3 but not in RFC1 or RFC4. Most
double mutants combining mutations in two RFC genes were
inviable. Except for the rfc1-K359R and
rfc4-K55E mutants, which were phenotypically similar to
wild type in every assay, the mutants were sensitive to DNA-damaging
agents. The rfc2-K71R and rfc4-K55R mutants
show checkpoint defects, most likely in the intra-S phase checkpoint. Regulation of the damage-inducible RNR3 promoter was
impaired in these mutants, and phosphorylation of Rad53p in response to DNA damage was specifically defective when cells were in S phase. No
dramatic defects in telomere length regulation were detected in the
mutants. These data demonstrate that the ATP binding function of
RFC2 is important for both DNA replication and checkpoint
function and, for the first time, that RFC4 also plays a
role in checkpoint regulation.
 |
INTRODUCTION |
Replication factor C
(RFC)1 is the eukaryotic
clamp loader that uses the energy of ATP hydrolysis to load the
replication clamp proliferating cell nuclear antigen (PCNA) onto the
DNA at a primer-template junction. RFC in yeast is a heteropentamer
that consists of a large subunit (Rfc1, 95 kDa) and four small subunits
(Rfc2-Rfc5, 36-40 kDa). The yeast Rfc subunits are all quite similar
to each other at the amino acid level (24-37%) and to the human Rfc
subunits. However, each yeast subunit shares the highest degree of
sequence homology with the analogous subunit from human RFC (reviewed
in Ref. 1). The sequence similarity is localized to the N-terminal half
of the subunits in regions termed RFC boxes II-VIII. Most notable are
the putative ATP-binding motifs in boxes III and V. The amino acids in
box III, the Walker A motif, create a characteristic fold, the P loop,
which forms a pocket for binding of the - and -phosphates of ATP
(2, 3).
Our biochemical studies reported in the second paper (4) of this series
show that four ATP molecules can bind to RFC when PCNA and
primer-template DNA are also present. This coincides with our current
understanding of the primary sequence determinants of ATP-binding
domains, which indicates that four of the five subunits comprising the
RFC complex contain consensus ATP-binding motifs. (see Fig.
1A). The Rfc5 subunit lacks critical residues in both the A
and B motifs and therefore this domain may have a more structural
function analogous to the ' subunit of Escherichia coli
DNA polymerase III holoenzyme (5).
Mutation of the conserved lysine residue to glutamic acid in the
RFC1, RFC2, RFC3, or
RFC4 gene resulted in mutant RFC complexes with varying
defects in in vitro assays. Complete loss of clamp loading
activity was observed in the RFC-2E complex (containing Rfc2-K71E), and
the RFC-3E complex (containing Rfc3-K59E) displayed only marginal
activity (6). The RFC-4E complex (containing Rfc4-K55E) showed
primarily a severe Km defect for ATP binding, and
the biochemical studies indicated that ATP binding to the Rfc4 subunit
is essential for clamp loading. Surprisingly, however, the RFC-1E
complex (containing Rfc1-K359E) was essentially like wild type,
contrasting sharply with reports of similar mutations in human RFC,
which abrogated the clamp loading activity of the mutant complex, and
suggesting that ATP binding to Rfc1 is not essential for clamp loading
in yeast (6-8).
In addition to the role of RFC in DNA replication, several of its
subunits appear to be involved in DNA repair (Ref. 9 and this study) as
well as checkpoint regulation. The cells progress through the cell
cycle in an orderly fashion with late events dependent upon the
successful completion of early events. When incompletely replicated DNA
or DNA damage is detected, a checkpoint is activated until DNA
synthesis is complete or the damage has been repaired. Mutations in two
components of the budding yeast RFC complex, RFC2 (10) and
RFC5 (11, 12) and mutations in Schizosaccharomyces
pombe rfc2+ (13) and rfc3+ (14) have
revealed a role for RFC in checkpoint regulation. In addition,
mutations in other DNA replication genes, namely the catalytic subunit
of DNA polymerase , POL2 (15) and a polymerase associated gene DPB11 (16, 17), show defects in the S phase checkpoint.
Our biochemical analysis has shown that ATP binding to the Rfc2, Rfc3,
and Rfc4 subunits is required for clamp loading, whereas ATP binding to
the Rfc1 subunit is dispensable for this process in vitro.
To determine whether these properties reflect those inside the cell or
whether ATP binding to Rfc subunits drives alternative pathways, we
have carried out a complementary genetic analysis of RFC ATP-binding
mutants. We have examined the in vivo phenotypes of both Lys
Glu and Lys Arg mutations in the ATP-binding motifs of the
RFC1, RFC2, RFC3, and RFC4
genes. The results of the genetic studies indicate that intact
ATP-binding motifs are critical in RFC2 and RFC3.
RFC2 and RFC4 mutants are defective in response to DNA
damage, indicating roles for these subunits in checkpoint regulation.
 |
EXPERIMENTAL PROCEDURES |
Strains--
The yeast strains used in this study are listed in
Table I. Standard growth media and yeast
genetic techniques were used. RFC2, RFC3, and
RFC4 deletion strains were created in the diploid strain
W303 (a gift from H. Klein). This strain was renamed PY73. PY90 and
PY91 were created by transforming PY73 with a
SalI/NheI digest of plasmids pBL628 and pBL627A,
respectively. Complementing plasmid pBL615 was transformed into the
diploid transformants, and appropriate spores were collected. PY92 was
made by transforming PY73 with a BsiWI/PvuII
digest of plasmid pBL629A, followed by transformation with pBL617 and
spore collection. PY94 was created in PY73 using a polymerase chain
reaction disruption method with pFA6a-kanMX6 (a generous gift from A. Wach) (18). pBL619 was transformed into the diploid strain, and
appropriate spores were collected. PY96-K71R/K55E was created by mating
PY91 with PY94-E, sporulating, and identifying the appropriate
haploids, followed by transformation with pBL630-R and a plasmid
shuffle on 5-fluoroorotic acid. PY103 is strain CH1578 (a generous gift
from C. Holm) that contains pBL641 in place of pCH1160. PY98-K359R/K71R
was created by mating PY103 with PY90-R, sporulating, and identifying
the appropriate his haploids, followed by transformation
with pBL643-R and a plasmid shuffle on 5-fluoroorotic acid.
PY99-K359R/K59R was created by mating PY103 with PY92-R, sporulating,
and identifying the appropriate his haploids. The strain
was transformed with pBL632 followed by growth to identify cells that
had lost the TRP1 plasmid (pBL623). Finally, the strain was
transformed with pBL642-R and a plasmid shuffle on 5-fluoroorotic acid
was performed. PY100-359R/K55E was created by mating PY103 with
PY94-E, sporulating, and identifying the appropriate his
haploids. The strain was transformed with pBL633-E followed by growth
to identify cells that had lost the TRP1 plasmid (pBL626). Finally, the strain was transformed with pBL642-R, and a plasmid shuffle on 5-fluoroorotic acid was performed. All strains were confirmed by Southern analysis. E. coli strains used include
DH5, ABLE C (Stratagene), XL1-Blue, and BW313 (dut ung).
View this table:
[in this window]
[in a new window]
|
Table I
Strains
For simplicity only viable strains are listed. All strains were created
for this study except PY73, which was obtained from Hannah Klein.
|
|
Plasmids--
The plasmids used throughout this study are listed
in Table II. pBL641 (RFC1,
URA3) is a complementing plasmid containing the entire
RFC1 sequence and was created by cloning a 922-bp
BamHI/BglII fragment containing the N terminus of
RFC1 into the BamHI site of plasmid pCH1160 (19).
pBL642 (RFC1, TRP1) was created by cloning the
5364-bp PvuI fragment from pBL641 into the 2871-bp PvuI fragment of pRS314. pBL642-R and pBL642-E
(rfc1-K359R or rfc1-K359E, TRP1) were
created by annealing mutagenic primers (1K359R,
5'-CCTGGTATTGGGCGTACGACTGCTGCTC-3'; 1K359E,
5'-CCTGGTATTGGGGAGACAACTGCTGCTC-3'; mutations are
underlined) to single-stranded, circular, uracil-containing pBL642 DNA
(20) and extending the primers with T7 DNA polymerase, followed by
ligation. These extension reactions were transformed into E. coli strain XL1-Blue. Isolates carrying the mutations were
identified by digestion of plasmid DNA with BsiWI (K359R) or
BsmAI (K359E). Isolates identified by restriction analysis were confirmed by sequencing. pBL643-R (rfc1-K359R,
HIS3) was created by cloning the 5365-bp PvuI
fragment from pBL642 into the 3054-bp fragment of pRS313. pBL643-E
(rfc1-K359E, HIS3) was created in yeast as
follows. pBL642-E was cotransformed into yeast strain PY73 with the
4522-bp PvuII fragment from pRS313. DNA was purified from
the his+ transformants and was transformed into E. coli strain ABLE C followed by confirmation of the plasmid by
restriction analysis.
pBL615 (RFC2, URA3) and pBL616 (RFC2,
TRP1) are complementing plasmids created by cloning the
2557-bp EcoRI/SalI fragment of pBS-RFC2 (a gift
from A. Sugino) into the EcoRI/SalI sites of
pRS316 and pRS314, respectively. pBL621 (rfc2-K71R,
TRP1) and pBL622 (rfc2-K71E, TRP1)
were created by annealing mutagenic primers (2K71R,
5'-CCAGGAACTGGTCGTACGTCTACC-3'; 2K71E,
5'-CCAGGAACTGGTGAAACGTCTACC-3'; mutations are underlined)
to single-stranded, circular, uracil-containing pBL616 DNA, followed by
the treatment described above. Correct isolates were detected by
sequencing (K71R) or by digestion with HphI (K71E) followed
by sequencing. pBL630-R (rfc2-K71R, LEU2) was
created by cloning the 2563-bp SalI/PstI fragment
from pBL621 into the SalI/PstI sites of pRS315.
pBL617 (RFC3, URA3) and pBL618 (RFC3,
TRP1) are complementing plasmids that were created by
cloning the 3085-bp EcoRI/BglII fragment of
pBL452 (24) into the EcoRI/BamHI sites of pRS316 or pRS314, respectively. pBL623 (rfc3-K59R, TRP1)
and pBL624 (rfc3-K59E, TRP1) were created by
annealing mutagenic primers (3K59R,
5'-CAATTGTAGAAGTACGACCGGTACCTGG-3'; 3K59E,
5'-CAATTGTAGAAGTTTCCCCGGTACCTGG-3'; mutations are
underlined) to single-stranded, circular, uracil-containing pBL618 DNA,
followed by the treatment described above. Correct isolates were
identified by digestion with BsiEI (K59R) or
BsaJI (K59E) followed by sequencing. pBL632
(Rfc3-K59R, HIS3) was created by cloning the
4981-bp PvuI fragment from pBL623 into the 3054-bp
PvuI fragment of pRS313.
pBL619 (RFC4, URA3) and pBL620 (RFC4,
TRP1) are complementing plasmids that were created by
cloning the 2241-bp BstEII (filled)/XhoI fragment
from pBL551 (a 7.5-kb BamHI yeast genomic fragment
containing the RFC4 locus cloned into pUC19) into the
EcoRI (filled)/XhoI sites of pRS316 and pRS314,
respectively. pBL625 (rfc4-K55R, TRP1) and pBL626
(rfc4-K55E, TRP1) were created by annealing
mutagenic primers (4K55R,
5'-CCAGGTATAGGTCGTACCACTTCGGTAC-3'; 4K55E,
5'-CCAGGTATAGGTGAGACCACTTCGGTAC-3'; mutations are
underlined) to single-stranded, circular, uracil-containing pBL620 DNA,
followed by the treatment described above. Correct isolates were
identified by sequencing. pBL633-R (rfc4-K55R,
HIS3) and pBL633-E (rfc4-K55E, HIS3)
were created by cloning the 4126-bp PvuI fragment from
pBL625 or pBL626, respectively, into the 3054-bp PvuI
fragment of pRS313.
pBL412, pBL413, pBL424, and pBL425 have been described previously (16).
Plasmids were created such that the RFC2 and RFC3 mutants could be overproduced under control of the GAL1/10
promoter. pBL412-R (GAL1/10-rfc2-K71R,
URA3) and pBL412-E (GAL1/10-rfc2-K71E, URA3) were created by replacing the 338-bp
PflMI/NheI in pBL412 with the same fragment from
pBL621 or pBL622, respectively. pBL413-R (GAL1/10-rfc3-K59R, LEU2) and pBL413-E
(GAL1/10-rfc3-K59E, LEU2) were
created by replacing the 397-bp MscI/NcoI
fragment of pBL413 with the same fragment from pBL623 or pBL624, respectively.
pBL627A contains the RFC2 gene, which has been disrupted by
inserting a hisG-URA3-hisG cassette into the
NdeI/HpaI sites of RFC2 in pBL616.
pBL628 contains the RFC2 gene, which has been disrupted by
inserting the kanMX6 gene into the
NdeI/HpaI sites of RFC2 in
pBS-RFC2.
Plasmid pBL457 contains the RFC3 gene, which has been
disrupted by inserting a hisG-URA3-hisG cassette into the
EcoNI/NcoI sites of RFC3 in plasmid
pBL452 (2). pBL629 contains the RFC3 gene, which has been
disrupted by inserting the kanMX6 gene (50) into the
EcoNI/NcoI sites of RFC3 in pBL452.
DNA Damage Sensitivity Measurements--
Sensitivity of the
mutants to growth on methyl methanesulfonate (MMS) or MMS survival
curves, sensitivity of the mutants to growth on hydroxyurea-containing
medium, or sensitivity to UV irradiation was determined as described
previously (21).
RNR3 Induction--
Plasmid pZZ2 (RNR3-lacZ,
URA3, CEN4, ARS1) was a gift from S. Elledge. RNR3 induction assays were carried out essentially as described (22). RFC deletion strains, complemented by
wild type or mutant RFC genes on TRP1 plasmids
plus plasmid pZZ2, were treated with 0.01% MMS for 5 h at
30 °C. All assays were done in triplicate and were repeated three to
five times.
Protein Extracts--
The mutant strains and isogenic wild type
controls were grown in YPD medium at 30 °C to OD660 = 2. In some experiments 100 mM hydroxyurea was added to the
cultures at an OD660 = 0.5, and growth continued at
30 °C until OD660 = 2 (6-9 h). Protein extracts were
made from 4-ml cultures essentially as described and were generally at
1 mg/ml (23). Extracts were fractionated on 10% acrylamide gels,
transferred to nitrocellulose, and blotted with immunopurified Rfc
antibodies as detailed in the legends to the figures. Detection was
with either with an ECL kit from Amersham Pharmacia Biotech or with an
alkaline phosphatase-conjugated secondary antibody followed by staining
with the BCIP/NBT FAST substrate from Sigma.
To measure phosphorylation of Rad53p, early log phase cells were
arrested with 10 µg/ml -factor (Sigma) for 2 h. Twenty
minutes after release from -factor, MMS was added to 0.1% final
concentration, and time points were taken. Extracts were fractionated
on 7.5% acrylamide gels, transferred to nitrocellulose, and blotted
with an anti-Rad53 antibody (yC-19) from Santa Cruz Biotechnology. Detection was with an ECL kit from Amersham Pharmacia Biotech.
 |
RESULTS |
Viability of ATP-binding Domain Mutants--
Site-directed
mutations were created in the ATP-binding motifs of the
RFC1, RFC2, RFC3, and RFC4
genes. The Rfc5 subunit lacks critical residues in both the Walker A
and B motifs of the ATP-binding domain and was therefore not subjected
to mutagenesis (Fig. 1A). As
with the ' subunit of the E. coli -complex, the
ATP-binding domain in Rfc5p likely is of structural importance
rather than of importance in binding ATP (5). The conserved
lysine in the Walker A motif was mutated to either an arginine or
glutamic acid residue (Fig. 1A). Arginine was chosen because
in some instances a Lys Arg mutation still permits ATP binding,
although in general the protein is biologically inactive (24-26). The
reversal of charge in the Lys Glu mutants was expected to virtually
abolish ATP binding and ATPase activity. Our biochemical analysis also
showed a more severe phenotype for the Lys Glu mutations than for
the analogous Lys Arg mutations (6). Fig. 1B outlines
the abbreviations used for the mutant strains throughout this
paper.

View larger version (42K):
[in this window]
[in a new window]
|
Fig. 1.
Comparison of ATP-binding domains in
RFC genes. A, the Walker A and B
motifs are shown. The consensus indicates critical residues within
these domains as defined by Neuwald et al. (47).
X is any amino acid, and is a hydrophobic residue. In
this study, the conserved lysine in the Walker A motif
(arrow) was altered to arginine or glutamic acid.
B, for simplicity, the strain names will be abbreviated in
figures and tables as shown.
|
|
A chromosomal deletion of each particular RFC was created as
described under "Experimental Procedures." Because all
RFC genes are essential, the chromosomal deletion was
complemented by the wild type RFC gene on a centromere
plasmid containing also the URA3 gene as a selectable
marker. These plasmids, as well as the ones described below, contained
the wild type or mutant RFC gene positioned behind its
natural promoter to ensure appropriate expression. A test of the
different wild type strains showed that they were similar to the
parental strain (W303) in growth and response to DNA-damaging agents
(data not shown). The appropriate strain with the wild type
RFC gene on a URA3 plasmid was transformed with a
second centromere plasmid with either TRP1, HIS3,
or LEU2 as a selectable marker and carrying either the wild
type RFC gene or the Lys Arg or Lys Glu mutant gene,
and cells containing both plasmids were plated on 5-fluoroorotic
acid-containing medium at 13, 23, or 30 °C. The cells that were able
to grow on this medium had lost the URA3 plasmid containing
the wild type gene and were therefore able to grow with the
RFC mutant gene. Colonies were replated on YPD plates, again
at various temperatures, and growth was determined. Table
III shows the results of these
experiments, and Fig. 2 shows growth
defects in the mutants at 13 °C.
View this table:
[in this window]
[in a new window]
|
Table III
Growth and repair defects of the mutants
For growth at 13 or 30 °C, 105, 104, 103,
and 102 cells were spotted as 10-µl drops on YPD plates and
growth was scored after 6-8 or 2-3 days, respectively. Growth on YPD
plates containing 110 mM hydroxyurea or 0.02% methyl
methanesulfonate was determined after 3-4 days at 30 °C.
Sensitivity to ultraviolet light was determined after plating of the
cells and irradiation of the plates at 100 J/m2. Wild type
survival was 44%. +++ indicates growth or survival like wild type;
++± indicates minimal defects in growth or survival; ++, +, and +/
indicate that growth or survival similar to wild type was observed at
approximately 10-, 100-, and 1000-fold greater cell amounts,
respectively; indicates that no growth was observed.
|
|

View larger version (99K):
[in this window]
[in a new window]
|
Fig. 2.
Defects in mutant cell growth at
13 °C. See Table III and "Experimental
Procedures" for details. +POL30 indicates that PCNA was
overproduced about 20-fold in the strain. wt, wild
type.
|
|
For each RFC gene, when the lysine was replaced by an
arginine, cell growth occurred. In fact, except for the
rfc2R mutant, no growth defects were observed in the mutants
at 30 °C. The rfc2R mutant strain grew very poorly on
synthetic selection medium, but adequate growth was observed when the
mutant was propagated on rich medium. In rich medium the
rfc2R mutant had a plating efficiency of ~30% and a
doubling time 1.6 times greater than wild type at 30 °C. An analysis
by fluorescence microscopy of the mutant showed an accumulation of
large budded cells. In ~60% of these arrested cells the nucleus was
positioned at the neck of the bud, consistent with an arrest in the
G2/M phase of the cell cycle because of replication defects
(data not shown). However, 40% of the cells did complete nuclear
division. The low plating efficiency of the mutant and the incomplete
cell cycle arrest are suggestive of a checkpoint defect in the
rfc2R strain, in addition to the replication defect (see
below). The rfc4R strain showed some cold sensitivity for growth.
When glutamic acid was substituted for lysine in RFC2 and
RFC3 lethality resulted. In contrast, the rfc1E
mutant had only a slight growth defect, and the rfc4E mutant
had no detectable defects (Fig. 2 and Table III).
Expression of Mutant Rfc Subunits--
An observed phenotypic
defect in a particular RFC mutant may not necessarily be due
to the inability of the mutant subunit to bind and/or hydrolyze ATP.
For instance, defects could also result if the mutant subunit were
unstable, not properly folded, failed to assemble into an appropriate
RFC complex with the other Rfc subunits, or failed to interact with
other proteins in the pathway, e.g. PCNA. Our E. coli expression studies of mutant RFCs have shown that all
complexes containing a single subunit with a Lys Glu mutation
assembled into isolatable complexes (6). However, if a mutant subunit
showed a profound instability in yeast, this could result in the
observation of a phenotypic defect that is unrelated to the ATP binding
properties of the mutant subunit. Conversely, overexpression of a
mutant subunit could conceivably suppress its phenotypic defect.
The levels of the mutant subunits were determined by Western analysis.
Both the mutant Rfc1R and the Rfc1E subunit were present at levels
comparable with the wild type control, i.e. differences in
protein levels were less than 2-fold (data not shown). Similarly, the
Rfc4R and Rfc4E subunits were present at levels comparable with wild
type, and those levels did not change significantly when the strains
were grown in the presence of hydroxyurea (Fig. 3). Furthermore, the Rfc2R and Rfc3R
subunits were also present at levels comparable with those of the
respective wild type subunits (data not shown). Expression of the Rfc2E
and Rfc3E subunits could not be directly measured because the mutations
were lethal. The RFC2, rfc2R, and
rfc2E genes were placed under control of the galactose-inducible GAL1-10 promoter cassette. Upon growth
on galactose-containing medium, overproduction of Rfc2E was equivalent to that of Rfc2 or Rfc2R, indicating that the stabilities of the mutant
and wild type proteins are similar (see below and Fig. 4A). The analogous result was
obtained with the Rfc3E subunit (Fig. 4B). These data
indicate that all mutant RFC genes were appropriately
expressed. Because defects in interactions with other components in the
pathway may also have phenotypic consequences, a suppression analysis
was carried out.

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 3.
Expression of Rfc4 mutants. Strains
PY94-K, PY94-R, and PY94-E were grown in YPD or YPD containing 100 mM hydroxyurea, and extracts were prepared as described
under "Experimental Procedures." The blots were probed with
anti-Rfc4 antibodies. wt, wild type.
|
|

View larger version (61K):
[in this window]
[in a new window]
|
Fig. 4.
Overproduction of RFC containing Rfc2E
or Rfc3E is deleterious. A, strain PY73 containing
pBL412 (RFC2), pBL412-R (rfc2R), pBL412-E
(rfc2E), or empty vector (None) was grown
overnight on selective SCGL medium (Table II). At a density of 5 × 106 cells/ml, galactose (2%) was added, and growth
continued for 6 h. Extracts were made, and Western analysis was
carried out as described under "Experimental Procedures." Rabbit
serum raised against Rfc4p cross-reacts with the other small Rfc
subunits. The serum was affinity-purified with Rfc2p expressed in
E. coli. The affinity-purified antibodies recognized both
Rfc2 and, more strongly, Rfc4, as indicated on the blot. B,
growth and analysis of PY73 containing pBL413 (RFC3),
pBL413-R (rfc3R), pBL413-E (rfc3E), or empty
vector (None) was similar as described above. Rabbit serum
raised against Rfc3p was affinity-purified with Rfc3p, expressed in
E. coli. The diffuse band indicated with an
asterisk is unrelated to Rfc subunits and was only observed
in the analysis of extracts and not of purified RFC. C,
plasmid-containing strains as indicated above or containing in addition
either pBL424 (RFC1, RFC3, RFC4, and
RFC5 under GAL1-10 control) or pBL425
(RFC1, RFC2, RFC4, and RFC5
under GAL1-10 control) were grown on selective SCGL medium
and then plated on selective SCGL plates containing either 2%
raffinose or 2% galactose. Plating efficiency (%) on galactose plates
versus raffinose plates was determined.
|
|
Overexpression of PCNA Suppresses Defects in rfc4R--
Because of
the known physical and functional interaction between RFC and PCNA, we
tested whether the observed defects were suppressed by overproduction
of PCNA, as has previously been observed in the case of the
rfc1-1 and rfc5-1 mutations (27, 28). The rfc2R and rfc4R strains were transformed with a
multicopy plasmid carrying the POL30 gene, which
overproduces PCNA about 20-fold, and growth was monitored. Whereas
growth of the rfc2R mutant remained unaffected, the cold
sensitivity of rfc4R was almost completely suppressed
(Fig. 2). Lethality of the rfc2E and rfc3E
mutants was not suppressed by overexpression of PCNA (data not shown).
Similarly, in an rfc5-1 strain, overexpression of
RAD24 was able to suppress both the temperature-sensitive
phenotype as well as the DNA damage sensitivity exhibited in this
mutant (12). The same experiments were carried out as above, but with
RAD24 on a multicopy plasmid. However, overexpression of
RAD24 in the rfc4R strain could not complement
the cold sensitivity of the mutant (data not shown).
Viability of Double RFC Mutants--
The viable single mutants
were combined by appropriate crossings to determine whether RFC could
tolerate the combined mutations in two of its subunits. Nine of the
thirteen possible double ATP-binding motif mutants were inviable (Table
III). The lethality of these double mutants may be the result of
combined ATP-binding defects but could also result from cumulative
defects in protein-protein interaction and complex stability. The
stability and activity of double mutant RFCs was not investigated in
our biochemical studies. More informative than the combined lethality
was the observation that four double mutant strains,
rfc1R/2R, rfc1R/3R, rfc1R/4E, and
rfc2R/4E, were viable. In the viable double mutants the
rfc1-K359R mutation is represented most often. The
rfc2R/4E double mutant has a much more severe phenotype than
the rfc2R strain. This mutant had a doubling time 2.1 times
that of wild type. In addition, the rfc1R/4E as well as the
rfc2R/4E strains were cold-sensitive for growth (Table III).
None of the single or double mutants were temperature-sensitive at
37 °C (data not shown).
Mutant RFC Complexes Display a Dominant Negative
Phenotype--
The mutant RFC genes that were inviable in
yeast were overexpressed in a wild type background (PY73) to determine
whether they displayed a dominant negative phenotype. Wild type and
mutant RFC2 and RFC3 genes were cloned into
multicopy plasmids under control of the galactose-inducible
GAL1-10 promoter. Previous studies have shown that an
approximately 20-100-fold overproduction of Rfc subunits was achieved
upon growth on galactose (29). Plasmid-containing cells were grown
under selective conditions on synthetic complete medium containing
raffinose as a noninducing carbon source and then plated onto the same
medium, but containing either raffinose or galactose. Overproduction of
the single subunits in strain PY73 was 10-20-fold for either the wild
type or mutant subunits (Fig. 4, A and B). If
overexpression of a mutant subunit were deleterious, this would be
evident by a decreased plating efficiency and/or poor colony growth on
galactose versus raffinose plates. Surprisingly, neither of
the two mutant genes with lethal mutations (rfc2E and
rfc3E) showed a dominant negative phenotype when
overexpressed individually (Fig. 4C). We reasoned that
perhaps these mutant gene products were not efficiently incorporated
into mutant RFC complexes in comparison with the wild type gene
products. Therefore, we determined whether dominant negative activity
could be achieved by overexpression of entire RFC complexes containing the respective mutant subunits.
When either the rfc2E or rfc3E mutant gene was
overexpressed in conjunction with the appropriate four wild type genes,
the plating efficiency was reduced by 60-70%. Moreover, those
colonies that did appear on the galactose plates grew very poorly (data not shown). As controls, overproduction of RFC complexes with rfc2-K71R, rfc3-K59R, or the wild type genes had
little or no effect. This analysis is somewhat complicated because
overproduction of wild type RFC complexes may also cause growth
impairment under some conditions (29). However, as the data in Fig.
4C show, the impairment caused by overexpression of mutant
complexes, specifically those containing mutations known to be
inviable, was more severe, indicating that these mutant complexes are
deleterious to yeast.
Sensitivity to DNA-damaging Agents--
Mutant strains were tested
for sensitivity to the DNA replication inhibitor hydroxyurea. The
RFC mutant strains were plated on rich medium (YPDA)
containing 110 mM hydroxyurea, and growth was scored after
3-4 days at 30 °C (Table III). All mutants and double mutants that
harbored the rfc2-K71R mutation failed to grow on
hydroxyurea-containing medium, indicative of a replication and/or
checkpoint defect in these mutants. Surprisingly, the rfc4R mutant failed to grow on hydroxyurea, whereas rfc4E showed
no defect. This was surprising because in previous investigations of
ATP-binding proteins a Lys Glu mutation invariably disrupted function much more severely than the conservative Lys Arg mutation (25, 30-34). Indeed, this expected phenotypic pattern was observed during our studies with the RFC1, RFC2, and
RFC3 genes. To investigate whether unexpected sequence
changes had occurred in these strains, the RFC4 mutant
plasmids were recovered from the yeast strains, and the mutant
RFC4 genes resequenced as well as recloned into fresh
plasmid vectors. No sequence changes beyond those originally introduced
were observed, and the studies with the new clones duplicated the
previous results. In addition, as stated before, no significant
differences in Rfc4 protein levels between the wild type and the
rfc4R and rfc4E mutants were detected, indicating that the observed phenotype is inherent to the mutation and not to
differences in protein levels (Fig. 3). Protein levels also remained
unaffected when the cells were grown in the presence of the replication
inhibitor hydroxyurea. The sensitivity to hydroxyurea exhibited by the
rfc4R mutant can be explained by its apparent checkpoint
defect (see below).
PCNA is involved in numerous DNA repair pathways (21, 35-38). Because
RFC loads PCNA onto DNA, it is expected to be involved in these
pathways as well. Therefore, the ATP-binding motif mutants were tested
for sensitivity to UV light and MMS. Most mutants displayed a similar
pattern of sensitivity to both of these agents (Table III), although
the mutants were generally more sensitive to MMS than to UV. A notable
exception was the rfc1R/4E strain that was sensitive to UV
but not to MMS.
Fig. 5 shows the results of a
typical time course analysis of MMS survival. For the RFC4
mutants we again observed a reversal of the expected phenotypes; the
rfc4R mutant was sensitive to MMS, whereas the
rfc4E mutant was indistinguishable from wild type. In fact,
a phenotype for the rfc4-K55E mutation could only be
uncovered when it was combined in a double mutant with
rfc1-K359R or with rfc2-K71R. These double
mutants were more sensitive to UV and MMS than the rfc1R or
rfc2R single mutants, respectively (Table III and Fig.
5).

View larger version (27K):
[in this window]
[in a new window]
|
Fig. 5.
Survival of mutant strains after MMS
treatment. Cell survival was measured following treatment in 0.5%
MMS for the indicated times. For details see "Experimental
Procedures."
|
|
Checkpoint Defects in RFC Mutants--
In wild type strains
transcription of the RNR3 gene as well as certain other
genes involved in DNA repair are up-regulated in response to DNA damage
or treatment with hydroxyurea (39). Defects in the S phase checkpoint
can result in a loss of induction of RNR3 in response to
damage, as observed in an rfc5-1 or DNA polymerase epsilon
mutant strain (15, 28). Mutant RFC strains containing single
and double ATP-binding domain mutations were examined for their ability
to induce RNR3 after MMS treatment, using a reporter system
in which the -galactosidase gene is placed under control of the RNR3
promoter (39). Compared with the corresponding wild type, the
rfc2R and rfc4R mutant strains were compromised in their ability to induce RNR3 following exposure to 0.01%
MMS (Fig. 6). The rfc2R mutant
induced RNR3 to only 15% of wild type, whereas the
rfc4R mutant induced RNR3 to 20% of wild type
levels. These data suggest that these mutants are impaired in
activation of the checkpoint in response to MMS.

View larger version (39K):
[in this window]
[in a new window]
|
Fig. 6.
Induction of RNR3 in
response to MMS. The cells were grown to early log phase and
treated with 0.05% MMS for 5 h. The cells were broken open, and
-galactosidase activity was measured in a liquid assay. Single
mutants and the corresponding wild type strains as well as the double
mutants were tested. Error bars indicate standard error.
Each assay in triplicate was carried out independently three to five
times. Wild type (WT) levels of induction were adjusted to
100. Absolute -galactosidase units for wild type strains after MMS
induction were: RFC1 = 124, RFC2 = 77, RFC3 = 79, RFC4 = 54, RFC1/RFC2 = 101, and
RFC3/RFC4 = 101.
|
|
Double ATP-binding motif mutants were also tested. The
rfc2R/4E mutant, like the rfc2R mutant was unable
to fully induce RNR3 in response to MMS-induced damage. The
rfc1R/4E mutant was also partially impaired in the ability
to up-regulate RNR3. Because this double mutant showed no
significant sensitivity to MMS, it was puzzling to note that this
strain should be partially defective in inducing RNR3 in
response to MMS damage. However, this strain is quite sensitive to UV
irradiation. Interestingly, the rfc1R/2R double mutant
strain was able to up-regulate RNR3, indicating that the
checkpoint defect exhibited by the rfc2R strain was
eliminated by the additional rfc1-K359R mutation. However,
the double mutant is still sensitive to DNA-damaging agents. These data
do suggest that RFC2 and RFC4 have a role in cell
cycle checkpoint regulation.
In a rfc5-1 mutant strain both sensitivity to damaging
agents and the checkpoint phenotypes were partially suppressed by
overproduction of Rad24p (12). To determine whether a similar
compensation occurred in the rfc4R mutant, RAD24
was overexpressed from a multicopy plasmid in the mutant strain, and
the RNR3 induction assay was repeated. No suppression of the
checkpoint defect was observed. Furthermore, the sensitivity of
rfc4R to DNA-damaging agents remained unchanged when
RAD24 was overexpressed (results not shown). The rfc2R strain could not be tested for complementation of the
RNR3 induction defect because of the poor growth of cells
containing both the RNR3 induction plasmid and the
RAD24 overexpression plasmid.
RAD53 encodes a protein kinase that plays a central role in
regulating the DNA damage response throughout the cell cycle (39). Rad53p is phosphorylated in a Mec1p-dependent manner and
via DUN1 leads to transcriptional induction of the DNA
damage regulon, which includes RNR3 and other genes
(reviewed in Ref. 40). To confirm a possible role for RFC2
and RFC4 in checkpoint regulation, phosphorylation of the
Rad53 protein in response to MMS was examined. In asynchronous
cultures, Rad53p was phosphorylated to an approximately equal extent in
both wild type and mutant strains exposed to MMS, suggesting that at
least some of the DNA damage checkpoints remained intact in these cells
(data not shown).
To examine damage-induced Rad53p phosphorylation during S phase, the
cells were synchronized with -factor, released, and then treated
with MMS during S phase. As shown in Fig.
7, the rfc2R mutant that
exhibited decreased RNR3 induction is impaired in its
ability to phosphorylate Rad53p. The most slowly migrating, multiply
phosphorylated forms of Rad53p did not appear in the rfc2R
mutant during the time scale of the experiment. In addition, the
hypophosphorylated form of Rad53p was continuously present in the
mutant, whereas in the wild type strain this form disappeared within 30 min of MMS treatment. The rfc4R mutant showed a similar but
less dramatic defect. Similar results were obtained when the cells were
irradiated with ultraviolet light (data not shown). The results for the
rfc2R/4E double mutant were similar to those for the single
rfc2R mutant, i.e. phosphorylation of Rad53p in response to damage was inhibited (data not shown).

View larger version (46K):
[in this window]
[in a new window]
|
Fig. 7.
Phosphorylation of Rad53p. The cells
were treated with -factor and released from arrest for 20 min at
30 °C prior to addition of MMS. Time points were every 30 min from
the time of MMS addition. The positions of Rad53p and the series of
phosphorylated Rad53p species (Pi-Rad53p) are indicated.
The asterisks indicate the positions of bands unrelated to
Rad53p.
|
|
Interestingly, examination of the rfc1R/4E double mutant,
which showed a reduced capacity for induction of RNR3 in
response to MMS (Fig. 6), did not reveal a MMS-induced defect in Rad53p phosphorylation either in asynchronous or in S phase cultures (data not
shown). Therefore, the checkpoint likely remains intact. Because this
double mutant is also not sensitive to MMS, the defect in
RNR3 induction upon treatment with MMS may originate from
other causes than the intra-S checkpoint.
Telomere Length Maintenance--
Mutations in RFC1 have
been shown to affect telomere length regulation (41). A dramatic size
increase of telomeres was observed in a cold-sensitive
rfc1-5 mutant strain, where the mutation (D513N) mapped
close to the ATP-binding domain. The mutant strains were tested to see
whether they exhibited altered telomere length maintenance. After
extended growth (>100 generations), the telomeres in the mutant
strains were approximately the same length as those of wild type
(results not shown). These results suggest that the telomere
lengthening defect is allele-specific and not related to ATP binding.
 |
DISCUSSION |
The mutational analysis described here and in the previous paper
has begun to elucidate the role of the ATP-binding motifs of the
Saccharomyces cerevisiae Rfc subunits. Table
IV summarizes the results of our genetic
analysis and compares them with the biochemical analysis of the same
mutants (6). There is a remarkable degree of agreement between the
growth phenotype and the in vitro clamp loading defect,
indicating that the major and essential function of RFC in the cell is
that of clamp loading. This agreement is immediately apparent for the
rfc2E and rfc3E mutations, which are lethal and
result in vitro in an almost total defect in clamp loading.
Similarly, the rfc2R mutation results in a moderate defect in clamp loading in vitro, and consequently the mutant
strain shows severe growth defects. The rfc3R and
rfc4E mutations confer a wild type growth phenotype. This
does not necessarily indicate that these latter mutant complexes are as
active as wild type in the cell but rather that clamp loading defects
if any do not result in observable growth defects under the conditions
tested. Interestingly, in vitro the RFC complex containing
either mutation is defective for clamp loading at low ATP
concentrations, but full clamp loading ability is restored at 1 mM ATP. Because in yeast neither one of these mutations
confers a growth defect, it is likely that the ATP
Km defect is suppressed by the high intracellular
levels of ATP of ~2 mM (42). Finally, RFC containing the
rfc1E mutation shows virtually no in vitro clamp
loading defect, although there are issues with protein stability, at
least when overexpressed in E. coli, and this mutation shows only a very minor defect in cell growth (Fig. 2).
View this table:
[in this window]
[in a new window]
|
Table IV
Biochemical and genetic defects in RFC mutants
The data for the biochemical properties are from Ref. 6. Minor,
>30% activity or ++± for growth; moderate, 5-30% activity; severe,
1-5% activity or + for growth; inactive, <1% activity;
Km, full or indicated activity at 1 mM
ATP but defective at 10 µM ATP.
|
|
These studies also point out the danger of using solely a genetic
approach to study the role of ATP binding/hydrolysis in a given pathway
and reaffirm the necessity to carry out an integrated genetic and
biochemical study to assess the functional importance of ATP binding to
putative ATP-binding proteins. Our genetic studies suggest that ATP
binding to Rfc1 and to Rfc4 may not be important or may even be
dispensable for clamp loading, because the Lys Glu mutation in
either subunit shows little or no phenotypic defect. However, our
biochemical studies show that ATP binding to Rfc4 is essential for
clamp loading, whereas ATP binding to Rfc1 appears to be dispensable
(6). On the other hand, both the genetic and biochemical studies
indicate that ATP binding to Rfc2 and Rfc3 is essential for RFC
function. The difference between mutations in the RFC2 and
RFC3 genes on one hand and the RFC4 gene on the
other hand results from the fact that the Rfc2E or Rfc3E subunit no
longer binds ATP, but the Rfc4E subunit still binds ATP, although only
at very high ATP concentrations. Therefore, both the in vivo
and in vitro phenotypes primarily reflect the high
sensitivity of the ATP-binding domain in Rfc2 or Rfc3 and the low
sensitivity of this domain in Rfc4 to mutagenesis.
Considering the lethal phenotype of the rfc2E mutation, we
expected that overproduction of this mutant subunit in a wild type yeast strain would have a dominant negative phenotype, but a dominant negative phenotype was only observed if the remaining four (wild type)
subunits were also overproduced (Fig. 4). One explanation for these
observations may be that the wild type Rfc2 subunit assembles more
readily into an RFC complex than the Rfc2E subunit, and therefore,
despite 10-20 fold overproduction of Rfc2E, the concentration of the
mutant RFC complex could be low. The deleterious phenotype observed
when the four remaining wild type subunits were overproduced together
with Rfc2E could then be rationalized by the accumulation of mutant
complexes that are defective in clamp loading. That the Rfc2E subunit
does assemble into a stable mutant RFC complex, at least when expressed
in E. coli, follows from our previous studies (6). A
parallel explanation can be offered for the mutant Rfc3E subunit,
overproduction of which has a phenotype similar to that of Rfc2E.
This study did not provide much new information about the role of ATP
in Rfc1 function. Although only minor defects were seen in the
RFC1 mutants, this does not mean that the consensus
ATP-binding motif in Rfc1 is not required for another function of RFC,
which was not assayed in this study. Alternatively, ATP binding to Rfc1 may play a regulatory role in the interconversion of RFC to alternative clamp loading complexes containing a Rfc2-5 core and an alternative large subunit, e.g. Rad24 (43).
The study of the RFC4 mutants have presented an interesting
deviation from the accepted rule that conservative Lys Arg
mutations show less severe phenotypes than the charge reversal Lys Glu mutations. In the case of RFC4, this pattern was
reversed. In vivo, the rfc4-K55R mutant had mild
growth defects, particularly at 13 °C, which were partially
suppressed by overexpression of PCNA. Control experiments showed
equivalent expression of the wild type and mutant Rfc4 proteins. A
checkpoint defect was also detected in rfc4R (Figs. 6 and
7). All of these phenotypes were absent in the rfc4E mutant.
In addition, two viable double mutants with rfc4-K55E,
i.e. rfc1R/4E and rfc2R/4E, could be
isolated, but no double mutants with rfc4-K55R were viable.
The conserved lysine residue in the Walker A motif of ATP-binding
proteins has been a favorite target for mutational studies. In general,
mutation of the conserved lysine in the Walker A domain of ATP-binding proteins results in only slight alterations in the P loop structure as
determined by x-ray crystallography and other methods (44-46). Therefore, biochemical or genetic defects associated with mutations in
this residue have in general been ascribed to defects in ATP binding
and/or hydrolysis rather than to defects in protein folding, protein
stability, or association with other subunits in a complex. Folding
and/or interaction defects can often be suppressed by overproduction of
an interacting protein in the pathway. Remarkably, the cold sensitivity
of the rfc4R mutant but not of the rfc2R mutant
was suppressed by overproduction of PCNA, consistent with the
interpretation that protein-protein interactions are affected in the
rfc4R mutant, perhaps through instability of the P loop in
the ATP-binding domain.
In addition to the role of RFC in DNA replication, this study provides
further evidence implicating RFC2 in checkpoint control and
for the first time suggests a role for RFC4 in this process. Between budding and fission yeast, all of the small subunits have now
been demonstrated to be involved in checkpoint regulation. RFC5 was the first RFC subunit to be identified in this role
(11, 28). The rfc5-1 mutant exhibits defects in checkpoints
that respond to DNA replication block or DNA damage in S phase. Rfc5p was later found to interact with the checkpoint protein Rad24p (12).
Since then, RFC2 was also shown to be involved in checkpoint control in both budding and fission yeast (10, 13). Although this study
did not implicate RFC3 in checkpoint control, recent work
suggests a checkpoint function for the S. pombe homolog
(14). All of these genetic data are consistent with a model in which the Rfc2-5 core forms a complex with Rad24 to function in response to
DNA damage during the S phase (43). The observation of a checkpoint
defect in the rfc2R mutant suggests a requirement for ATP
binding and/or hydrolysis during checkpoint function.
In conclusion, an integrated genetic and biochemical analysis of the
ATP-binding domains of four Rfc subunits indicates that ATP binding to
the Rfc2, Rfc3, and Rfc4 subunits of RFC is required for clamp loading,
but ATP binding to Rfc1 is dispensable. Moreover, no or only marginal
defects were detected in the RFC1 mutants. However, this
study was limited to phenotypic studies related to cell growth, damage
sensitivity, and checkpoint function. It may well be possible that
defects exist in other pathways such as recombination and chromosome
segregation. Further studies are required to elucidate the role of the
ATP-binding domain in the Rfc1 subunit.
 |
ACKNOWLEDGEMENTS |
We thank Connie Holm, Akio Sugino, Hannah
Klein, Steve Elledge, and Achim Wach for strains and plasmids, Kim
Gerik with help in plasmid construction, and John Majors for critical
discussions during the course of this work.
 |
FOOTNOTES |
*
This work was supported in part by Grant GM32431 from the
National Institutes of Health.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The on-line version of this article (available at
http://www.jbc.org) contains figures for the Appendix.
To whom correspondence should be addressed: Dept. of
Biochemistry and Molecular Biophysics, Washington University
School of Medicine, 660 S. Euclid Ave., St. Louis, MO 63110. E-mail: burgers@biochem.wustl.edu.
Published, JBC Papers in Press, June 29, 2001, DOI 10.1074/jbc.M011671200
 |
ABBREVIATIONS |
The abbreviations used are:
RFC, replication
factor C;
Rfc2-5, complex of Rfc2p, Rfc3p, Rfc4p, and Rfc5p;
Rfcx, xth subunit of RFC;
PCNA, proliferating cell nuclear antigen;
MMS, methylmethane
sulfonate;
bp, base pair.
 |
REFERENCES |
| 1.
|
Cullmann, G.,
Fien, K.,
Kobayashi, R.,
and Stillman, B.
(1995)
Mol. Cell. Biol.
15,
4661-4671
|
| 2.
|
Saraste, M.,
Sibbald, P. R.,
and Wittinghofer, A.
(1990)
Trends Biochem. Sci.
15,
430-434
|
| 3.
|
Traut, T. W.
(1994)
Eur. J. Biochem.
222,
9-19
|
| 4.
|
Gomes, X. V.,
Gary Schmidt, S. L.,
and Burgers, P. M.
(2000)
J. Biol. Chem.
276,
34776-34783
|
| 5.
|
Guenther, B.,
Onrust, R.,
Sali, A.,
O'Donnell, M.,
and Kuriyan, J.
(1997)
Cell
91,
335-345
|
| 6.
|
Gary Schmidt, S. L.,
Gomes, X. V.,
and Burgers, P. M.
(2000)
J. Biol. Chem.
276,
34784-34791
|
| 7.
|
Cai, J.,
Yao, N.,
Gibbs, E.,
Finkelstein, J.,
Phillips, B.,
O'Donnell, M.,
and Hurwitz, J.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
11607-11612
|
| 8.
|
Podust, V. N.,
Tiwari, N.,
Ott, R.,
and Fanning, E.
(1998)
J. Biol. Chem.
273,
12935-12942
|
| 9.
|
McAlear, M. A.,
Tuffo, K. M.,
and Holm, C.
(1996)
Genetics
142,
65-78
|
| 10.
|
Noskov, V. N.,
Araki, H.,
and Sugino, A.
(1998)
Mol. Cell. Biol.
18,
4914-4923
|
| 11.
|
Sugimoto, K.,
Shimomura, T.,
Hashimoto, K.,
Araki, H.,
Sugino, A.,
and Matsumoto, K.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
7048-7052
|
| 12.
|
Shimomura, T.,
Ando, S.,
Matsumoto, K.,
and Sugimoto, K.
(1998)
Mol. Cell. Biol.
18,
5485-5491
|
| 13.
|
Reynolds, N.,
Fantes, P. A.,
and MacNeill, S. A.
(1999)
Nucleic Acids Res.
27,
462-469
|
| 14.
|
Shimada, M.,
Okuzaki, D.,
Tanaka, S.,
Tougan, T.,
Tamai, K. K.,
Shimoda, C.,
and Nojima, H.
(1999)
Mol. Biol. Cell
10,
3991-4003
|
| 15.
|
Navas, T. A.,
Sanchez, Y.,
and Elledge, S. J.
(1996)
Genes Dev.
10,
2632-2643
|
| 16.
|
Araki, H.,
Leem, S. H.,
Phongdara, A.,
and Sugino, A.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
11791-11795
|
| 17.
|
Wang, H.,
and Elledge, S. J.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
3824-3829
|
| 18.
|
Wach, A.
(1996)
Yeast
12,
259-265
|
| 19.
|
Howell, E. A.,
McAlear, M. A.,
Rose, D.,
and Holm, C.
(1994)
Mol. Cell. Biol.
14,
255-267
|
| 20.
|
Burgers, P. M. J.,
and Klein, M. B.
(1986)
J. Bacteriol.
166,
905-913
|
| 21.
|
Ayyagari, R.,
Impellizzeri, K. J.,
Yoder, B. L.,
Gary, S. L.,
and Burgers, P. M.
(1995)
Mol. Cell. Biol.
15,
4420-4429
|
| 22.
|
Zhou, Z.,
and Elledge, S.
(1992)
Genetics
131,
851-866
|
| 23.
|
Foiani, M.,
Marini, F.,
Gamba, D.,
Lucchini, G.,
and Plevani, P.
(1994)
Mol. Cell. Biol.
14,
923-933
|
| 24.
|
Hishida, T.,
Iwasaki, H.,
Yagi, T.,
and Shinagawa, H.
(1999)
J. Biol. Chem.
274,
25335-25342
|
| 25.
|
Thiagalingam, S.,
and Grossman, L.
(1991)
J. Biol. Chem.
266,
11395-11403
|
| 26.
|
Konola, J. T.,
Logan, K. M.,
and Knight, K. L.
(1994)
J. Mol. Biol.
237,
20-34
|
| 27.
|
McAlear, M. A.,
Howell, E. A.,
Espenshade, K. K.,
and Holm, C.
(1994)
Mol. Cell. Biol.
14,
4390-4397
|
| 28.
|
Sugimoto, K.,
Ando, S.,
Shimomura, T.,
and Matsumoto, K.
(1997)
Mol. Cell. Biol.
17,
5905-5914
|
| 29.
|
Gerik, K. J.,
Gary, S. L.,
and Burgers, P. M.
(1997)
J. Biol. Chem.
272,
1256-1262
|
| 30.
|
Griffiths, D. J.,
Barbet, N. C.,
McCready, S.,
Lehmann, A. R.,
and Carr, A. M.
(1995)
EMBO J.
14,
5812-5823
|
| 31.
|
Naiki, T.,
Shimomura, T.,
Kondo, T.,
Matsumoto, K.,
and Sugimoto, K.
(2000)
Mol. Cell. Biol.
20,
5888-5896
|
| 32.
|
Titolo, S.,
Pelletier, A.,
Sauve, F.,
Brault, K.,
Wardrop, E.,
White, P. W.,
Amin, A.,
Cordingley, M. G.,
and Archambault, J.
(1999)
J. Virol.
73,
5282-5293
|
| 33.
|
Wang, B.,
Feng, L.,
Hu, Y.,
Huang, S. H.,
Reynolds, C. P.,
Wu, L.,
and Jong, A. Y.
(1999)
J. Biol. Chem.
274,
8291-8298
|
| 34.
|
Mizushima, T.,
Takahashi, N.,
and Stillman, B.
(2000)
Genes Dev.
14,
1631-1641
|
| 35.
|
Matsumoto, Y.,
Kim, K.,
and Bogenhagen, D. F.
(1994)
Mol. Cell. Biol.
14,
6187-6197
|
| 36.
|
Torresramos, C.,
Yoder, B. L.,
Burgers, P. M.,
Prakash, S.,
and Prakash, L.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
9676-9681
|
| 37.
|
Umar, A.,
Buermeyer, A. B.,
Simon, J. A.,
Thomas, D. C.,
Clark, A. B.,
Liskay, R. M.,
and Kunkel, T. A.
(1996)
Cell
87,
65-73
|
| 38.
|
Johnson, R. E.,
Kovvali, G. K.,
Guzder, S. N.,
Amin, N. S.,
Holm, C.,
Habraken, Y.,
Sung, P.,
Prakash, L.,
and Prakash, S.
(1996)
J. Biol. Chem.
271,
27987-27990
|
| 39.
|
Allen, J. B.,
Zhou, Z.,
Siede, W.,
Friedberg, E. C.,
and Elledge, S. J.
(1994)
Genes Dev.
8,
2401-2415
|
| 40.
|
Longhese, M. P.,
Foiani, M.,
Muzi-Falconi, M.,
Lucchini, G.,
and Plevani, P.
(1998)
EMBO J.
17,
5525-5528
|
| 41.
|
Adams, A. K.,
and Holm, C.
(1996)
Mol. Cell. Biol.
16,
4614-4620
|
| 42.
|
Schuddemat, J.,
van den Broek, P. J.,
and van Steveninck, J.
(1988)
Biochim. Biophys. Acta
937,
81-87
|
| 43.
|
Green, C. M.,
Erdjument-Bromage, H.,
Tempst, P.,
and Lowndes, N. F.
(2000)
Curr. Biol.
10,
39-42
|
| 44.
|
O'Brien, M. C.,
Flaherty, K. M.,
and McKay, D. B.
(1996)
J. Biol. Chem.
271,
15874-15878
|
| 45.
|
Yang, g.,
Sandalova, T.,
Lohman, K.,
Lindqvist, Y.,
and Rendina, A. R.
(1997)
Biochemistry
36,
4751-4760
|
| 46.
|
Smith, C. V.,
and Maxwell, A.
(1998)
Biochemistry
37,
9658-9667
|
| 47.
|
Neuwald, A. F.,
Aravind, L.,
Spouge, J. L.,
and Koonin, E. V.
(1999)
Genome Res.
9,
27-43
|
Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
I.-t. Cho, D.-h. Kim, Y.-H. Kang, C.-H. Lee, T. Amangyelid, T. A. Nguyen, J. Hurwitz, and Y.-S. Seo
Human Replication Factor C Stimulates Flap Endonuclease 1
J. Biol. Chem.,
April 17, 2009;
284(16):
10387 - 10399.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. M. Berkowitz, K. H. Kaestner, and T. A. Jongens
Germline expression of mammalian CTF18, an evolutionarily conserved protein required for germ cell proliferation in the fly and sister chromatid cohesion in yeast
Mol. Hum. Reprod.,
March 1, 2008;
14(3):
143 - 150.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Majka, B. Y. Chung, and P. M. J. Burgers
Requirement for ATP by the DNA Damage Checkpoint Clamp Loader
J. Biol. Chem.,
May 14, 2004;
279(20):
20921 - 20926.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. A. Anderson and N. D. Perkins
Regulation of RelA (p65) Function by the Large Subunit of Replication Factor C
Mol. Cell. Biol.,
January 15, 2003;
23(2):
721 - 732.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. M. Hingorani and M. M. Coman
On the Specificity of Interaction between the Saccharomyces cerevisiae Clamp Loader Replication Factor C and Primed DNA Templates during DNA Replication
J. Biol. Chem.,
November 27, 2002;
277(49):
47213 - 47224.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Dua, D. L. Levy, C. M. Li, P. M. Snow, and J. L. Campbell
In Vivo Reconstitution of Saccharomyces cerevisiae DNA Polymerase epsilon in Insect Cells. PURIFICATION AND CHARACTERIZATION
J. Biol. Chem.,
March 1, 2002;
277(10):
7889 - 7896.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. V. Gomes and P. M. J. Burgers
ATP Utilization by Yeast Replication Factor C. I. ATP-MEDIATED INTERACTION WITH DNA AND WITH PROLIFERATING CELL NUCLEAR ANTIGEN
J. Biol. Chem.,
September 7, 2001;
276(37):
34768 - 34775.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. L. G. Schmidt, X. V. Gomes, and P. M. J. Burgers
ATP Utilization by Yeast Replication Factor C. III. THE ATP-BINDING DOMAINS OF Rfc2, Rfc3, AND Rfc4 ARE ESSENTIAL FOR DNA RECOGNITION AND CLAMP LOADING
J. Biol. Chem.,
September 7, 2001;
276(37):
34784 - 34791.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|